This post from Immigration Practice Group Co-Chair, Catherine Wadhwani, suggests J-1 Physician Waiver sponsorship as a means of meeting patient needs.
Continue Reading J-1 Waivered Physicians – Meeting Patient Needs
FTC and OCR Issue Joint Website Tracking Warning Letter
If you are involved with any health information, even if you are not covered by HIPAA, you should be aware of the government’s recent position that there may be serious
Continue Reading FTC and OCR Issue Joint Website Tracking Warning LetterBrightree and MatrixCare Support Interoperability
Brightree by ResMed (“Brightree”), a cloud-based management software platform for healthcare providers, has conducted its biannual interoperability survey, and issued its corresponding biannual Interoperability and Engagement Research Report. Most notably
Continue Reading Brightree and MatrixCare Support InteroperabilityThe CFPB’s Latest Report on Medical Credit Cards Addresses Misleading Activity by Providers.
Federal regulators are focusing in on medical credit cards and financing plans and the roles that healthcare providers have in facilitating them. The Consumer Financial Protection Bureau (“CFPB”) is a
Continue Reading The CFPB’s Latest Report on Medical Credit Cards Addresses Misleading Activity by Providers.Are We There Yet? New HIPAA Privacy Protections for Reproductive Health Data May Be Just Ahead
This blog post was first published on the Fox HIPAA & Health Information Technology Blog. It covers a critical new rule proposed by the Office For Civil Rights to close
Continue Reading Are We There Yet? New HIPAA Privacy Protections for Reproductive Health Data May Be Just Ahead
Telehealth Practitioners Must Be Aware of the DEA’s Proposed New Rules for Prescribing Controlled Substances via Telemedicine
Telehealth practitioners must take note of the DEA’s proposed rule making that would impact the way telehealth practitioners can prescribe controlled substances.
The Ryan Haight Act and the Proposed Rules
Continue Reading Telehealth Practitioners Must Be Aware of the DEA’s Proposed New Rules for Prescribing Controlled Substances via Telemedicine
Reduce Your Risk (And We’re Not Just Talking COVID-19 Vaccines)
When COVID-19 was on the rise, ransomware attacks were right alongside it. A new investigation published in JAMA Health Forum found that ransomware attacks more than doubled in the last
Continue Reading Reduce Your Risk (And We’re Not Just Talking COVID-19 Vaccines)Is it Really Fraud? The Supreme Court Will Decide
Two landmark cases fraught with False Claim Act (“FCA”) allegations of fraudulent billing for prescription drugs against food and pharmacy chains are making their way from the Seventh Circuit to
Continue Reading Is it Really Fraud? The Supreme Court Will DecideRansomware Attacks Against Healthcare Providers Continue to Increase
The systems healthcare providers use to provide safe and reliable patient care, and their confidential patient information, provide attractive targets for hackers using ransomware to extort payment. As a result
Continue Reading Ransomware Attacks Against Healthcare Providers Continue to Increase
Five Differences Between the Federal Anti-Kickback Statute and the Federal Stark Law
Physicians around the country are familiar with the Federal Anti-Kickback Statute (“AKS”) (42 U.S.C. § 1320a-7b(b)) and the Federal Physician Self-Referral Law, commonly referred to as the Stark Law (“Stark”)
Continue Reading Five Differences Between the Federal Anti-Kickback Statute and the Federal Stark Law